| Rajamma Elizabeth Kalia, MD | |
|
150 E Medical Center Blvd, Suite C, Webster, TX 77598-4301 | |
| (281) 212-2400 | |
| (281) 212-2499 |
| Full Name | Rajamma Elizabeth Kalia |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 150 E Medical Center Blvd, Webster, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134163355 | NPI | - | NPPES |
| 135658610 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | TXF8531 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rajamma Elizabeth Kalia, MD 150 E Medical Center Blvd, Suite C, Webster, TX 77598-4301 Ph: (281) 212-2400 | Rajamma Elizabeth Kalia, MD 150 E Medical Center Blvd, Suite C, Webster, TX 77598-4301 Ph: (281) 212-2400 |
News Archive
ESTEVE announces the recent publication of data from the Phase I clinical trial programme of a novel, highly potent and selective, once-daily, S1RA E-52862, developed by the ESTEVE R&D team, in the British Journal of Clinical Pharmacology.
The unrestricted presence and participation of patients' family members and friends provides wide-reaching benefits, both medically and emotionally, according to a new Practice Alert from the American Association of Critical-Care Nurses.
This Lancet Infectious Diseases editorial responds to the Global HIV/AIDS Response 2011 progress report (.pdf) launched by WHO, UNICEF, and UNAIDS on November 30, writing that the report "contains much good news on treatment and prevention, but the gains made by past efforts are jeopardized by the ongoing global financial crisis and dwindling funds."
The New York Commission on Health Care Facilities in the 21st Century on Monday approved a list of policy recommendations that would change the way health care is financed in the state, the New York Times reports.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base).
› Verified 7 days ago
Melanie Suzanne Williams, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1010 S Ponds Dr, Webster, TX 77598 Phone: 713-442-4300 | |
Stephanie Pocsik, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 16 Professional Park, Webster, TX 77598 Phone: 281-332-3503 Fax: 281-332-3506 | |
Candace P Siegel, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1010 S Ponds Dr, Webster, TX 77598 Phone: 713-442-4300 | |
Dr. Lekshmi Daram, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1010 S Ponds Dr, Webster, TX 77598 Phone: 713-442-4300 | |
Dr. Avolonne Morgan Kimble, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 333 N Texas Ave Ste 4300, Webster, TX 77598 Phone: 281-338-5437 Fax: 281-338-9543 | |
Ragini Miryala, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 205 E Medical Center Blvd, Ste B, Webster, TX 77598 Phone: 281-480-7832 Fax: 281-480-7504 | |
Gwendolyn A Williams, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1010 S Ponds Dr, Webster, TX 77598 Phone: 713-442-4300 |